Polish Health Ministry Prepares E-Cigarette Ban Legislation for Public Consultation

Regulations by 2FIRSTS.ai
Mar.20.2024
Polish Health Ministry Prepares E-Cigarette Ban Legislation for Public Consultation
Poland's Ministry of Health is preparing a ban on e-cigarettes, with a draft expected to be submitted for public consultation soon.

According to the Polish media outlet portalsamorzadowy, Deputy Minister of Health Wojciech Konieczny stated during a Senate committee meeting on March 19 that preparations have begun within the Ministry of Health for a ban on e-cigarettes. The draft is expected to be submitted for public consultation in the coming weeks.

 

Konecni stated that this ban would require approximately six months of notification within the European Union (EU), but the legislation would take some time to come into effect. Nevertheless, he assured that the Ministry of Health would introduce such a ban, which may also include prohibiting the marketing of disposable e-cigarettes or non-tobacco heating products.

 

At the same time, the Department of Health is also preparing a bill regarding the regulation of flavored e-cigarettes, which is expected to be implemented by November at the latest.

 

Co-chievni explained that the committee's debate revolves around two different issues - whether these devices are tobacco products or non-tobacco products, with the former being governed by tobacco laws and the latter only subject to product safety regulations.

 

The Minister also pointed out the prohibition on using such devices in vehicles with children or pregnant women, banning advertising for them, and the need for standardized packaging or the introduction of more control options.

 

Beata Małecka-Libera, chairwoman of the Senate Health Committee, is calling for immediate oversight of compliance with existing regulations, rather than waiting for the ban to take effect.

 

Currently, the Senate committee has approved the proposal for the Ministry of Health to establish a special team with the aim of urgently recalling all products on the market that violate current laws.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
British American Tobacco (BAT) CEO Tadeu Marroco said the group will continue to invest in equipment and technology in Italy and expand capacity for next-generation tobacco products such as e-cigarettes and heated tobacco. BAT’s Trieste innovation hub is slated to receive a total investment of 500 million euros by 2027 and add 16 new production lines.
Feb.03 by 2FIRSTS.ai
UK Disposable Vape Ban Fallout: Convenience Vape Units Down 20.8%, Retailers Hit by a “Triple Whammy,” Talysis Says
UK Disposable Vape Ban Fallout: Convenience Vape Units Down 20.8%, Retailers Hit by a “Triple Whammy,” Talysis Says
UK convenience insight agency Talysis says vape unit sales in convenience stores have fallen 20.8% and value sales 12.7% nearly eight months after the disposable vape ban took effect.
Jan.28 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
EVO NXT 2026 Offers Unique Insights Into A Dynamic Industry
Feb.09